Auth bypass in Ascensia Contour Diabetes

CVE-2018-18976

An issue was discovered in the Ascensia Contour NEXT ONE application for iOS and Android before 2019-01-15. An attacker may retrieve encrypted medical information of any user of the Ascensia cloud platform by performing Direct Object References with a series of user ID values. (This information can be decrypted through a different vulnerability.)

Vulnerability class: IDOR (Insecure Direct Object Reference)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N.

EPSS exploit prediction

EPSS: 0.011 (65.4th percentile), scored .

Low probability of exploitation in the next 30 days, but still tracked. 65th percentile — 65.4% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2018-18976: held from 0.011 to 0.011.

EPSS over last 30 days · oldest: 0.011 · newest: 0.011 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2018-18976?
CVE-2018-18976 is a medium-severity vulnerability in Ascensia Contour Diabetes, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 5.3/10. Published 2019-05-06.
How severe is CVE-2018-18976?
Medium severity. CVSS v3 base score is 5.3 out of 10.